SynthesisPeerJ2025
Long-term glycemic variability and the risk of heart failure: a meta-analysis.
Synthesis in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Long-term glycemic variability (GV) has emerged as a potential cardiovascular risk factor beyond average glycemic levels. However, its association with the risk of heart failure (HF) remains unclear. This meta-analysis evaluated the relationship between long-term GV and the incidence of HF in adults. Methods: We systematically searched PubMed, Embase, and Web of Science from inception to January 31, 2025, for observational studies assessing the association between long-term GV-measured by variability indices of hemoglobin A1c (HbA1c) or fasting plasma glucose-and HF risk. Pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated using random-effects models by incorporating the influence of heterogeneity. Results: Eleven datasets from 10 studies involving 4,229,377 adults were included. Compared with participants with low GV, those with high long-term GV had a significantly increased risk of incident HF (HR = 1.69; 95% CI [1.38-2.06]; Conclusion: High long-term GV is independently associated with an increased risk of HF. These findings underscore the clinical relevance of GV monitoring in cardiovascular risk assessment, including risk stratification for the incidence of HF.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.